News
-
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
Telomir Pharmaceuticals, Inc. appoints Dr. Itzchak Angel as Chief Scientific Advisor to lead developments in longevity science and advance Telomir-1 small molecule for age-related conditions in humans and animals -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
Telomir-1, a small molecule by Telomir Pharmaceuticals, shows promising results in promoting life quality and longevity in senior dogs. The pre-clinical-stage company's research aims to lead developments in longevity science through the treatment of age-related conditions